You are on page 1of 4

EXECUTIVE SUMMARY

REPORT #10-001
The Contract Research Market for

Overview
January 2010
Print: $3,200 $2,700 Drug Discovery Technologies:
Electronic (PDF): $5,200 $4,500
Print + Electronic: $5,200 $4,500
Opportunities for Life Science Suppliers

This pre-publication discount price is only available until January 31, 2010!

Overview

Company Information
In an era where funds are tight and competition is steep, Beyond informing the life science supplier, The Contract
life science suppliers continue to battle fiercely over Research Market for Drug Discovery Technologies:
pharmaceutical and biotech lab budgets, and the winners Opportunities for Life Science Suppliers was designed
undoubtedly leverage their position by targeting new to provide a marketing roadmap for CROs as well. In
markets—or serving current ones better. As lab budgets this report, pharmaceutical and biotech labs outline
remain constricted, pharmaceutical and biotech labs are the selection criteria used for choosing CROs, the most
outsourcing pre-clinical and drug discovery services to popular CROs, contract budget details, anticipated
create efficiency and offload the need to maintain staff, budgetary changes and customer satisfaction with the
instruments and consumables for irregularly scheduled level of service provided by CROs. Outsourcing labs

Order Form
projects and projects that extend beyond their scope. The identify the top three attributes that were considered
smart supplier recognizes that the relationship between when choosing a CRO, and the percentage of pre-clinical/
the pharmaceutical/biotech industries and Contract drug discovery lab budget that was spent on each type of
Research Organizations (CROs) presents an opportunity— pre-clinical/drug discovery service in FY2009, and how
quick responders to fluctuations in the relationship that number is expected to change in 2010.
between these adjacent markets will ride a trend that can
steadily impact revenues.
This report will help you to:
But the challenge lies in applying metrics to this • Characterize the potential of the preclinical
relationship, so that suppliers can anticipate customer CRO market
needs based on the flow—and type— of research • Project the size and share of the CRO market
outsourced to CROs. In our January 2010 report, for consumables and instrumentation for
The Contract Research Market for Drug Discovery 2010
Technologies: Opportunities for Life Science Suppliers,
• Pinpoint key purchase decision points along
we surveyed over 100 scientists from pharmaceutical
the outsourcing chain
and biotech labs to determine services earmarked for
outsourcing, how research partners are chosen and what • Identify opportunities for capturing CRO
market share
portion of lab budgets have been allocated for contracts.
In addition, we asked over 100 CRO scientists about
the types of drug discovery services they provide, and
The appendix in this report contains a
the budgets they have allocated for instruments and
comprehensive directory of CROs, which
consumables. Specifically, the report details types of life science suppliers can use to develop
products used in CRO research and vendors most chosen key marketing and sales contacts within
as supplier-of-choice by CROs. New contracts continually these organizations.
present windows of opportunity for suppliers to gain
a presence in CRO accounts; this study identifies the BioInformatics
market insights from gene to drug
criteria used in choosing vendors for instrumentation and
consumable products. Furthermore, we profiled the typical 2111 Wilson Blvd
CRO scientist, so that suppliers can tailor marketing Suite 250
campaigns to address the needs of this unique consumer. Arlington, VA 22201
www.gene2drug.com
703.778.3080 x13
703.778.3081 (fax)

The Contract Research Market for Drug Discovery Technologies Executive Summary Page 1 of 4
©2009 BioInformatics, LLC
Other Recent Publications*
Life Science Marketing

Overview
#09-006 The Market Outlook for Research Products in FY2010 November 2009 235 Pages
#09-005 New Media Marketing Channels: Creating Effective Online Life Science Promotional Videos September 2009 220 Pages
#09-004 The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III May 2009 175 Pages
#09-003 Exploring the Epigenetics Market: Opportunities for Product Placement and Innovation July 2009 148 Pages
#09-002 Capitalizing on New Opportunities for Stem Cell Products April 2009 263 Pages
#09-001 Prospering in a Down Market: Strategies for Life Science Suppliers March 2009 159 Pages

Company Information
#08-047 The Brave New World of Scientific Publishing November 2008 154 Pages
#08-019 Enabling Discovery: The 2008 Life Science Industry Awards TM June 2008 101 Pages
#08-008 Instrumentation Service Contracts: Opportunities for Differentiation July 2008 136 Pages
#08-007 Protein Research: Strategies for Marketing to Chemists and Biologists September 2008 123 Pages
#08-006 Understanding Switching Dynamics: Maximizing Customer Retention in the Life Science March 2008 173 Pages
#08-004 Life Science Product Catalogs: Techniques to Increase Sales March 2008 92 Pages
#08-003 Conference & Exhibit Strategies in the Life Sciences: What’s Working Now February 2008 135 Pages
#08-002 Advertising to Life Scientists: Resolving the Print vs. Online Dilemma February 2008 105 Pages

Order Form
* See Web site www.gene2drug.com for a complete listing.

Why choose our reports?


Sources of Independent, Unbiased Research Carefully Selected Survey Participants
Unlike reports from other firms that are based on an When others promote results from their online surveys,
analyst’s subjective summary of information from publicly they fail to mention the uncontrolled nature of their
available sources, our reports are based on the results broadcast email invitations. To provide you with the most
of detailed surveys of hundreds—even thousands—of valid and accurate results possible, the respondents to our
scientific and medical professionals who buy your surveys are members of our unique online panel—The
products. Science Advisory Board—which consists of more than
46,000 verified life science and biomedical professionals
Developed by a Team of Experts who have agreed to take part in our surveys, focus groups
Our questionnaires are developed by a multi- and other market research activities. These respondents
disciplinary team of scientists, industry veterans and are carefully selected based on their professional
market research experts with years of experience. These qualifications, market segments and geographic
professionals understand that survey questions need to regions—we can even select them based on the products
be asked in a way that ensures the answers will directly they use and their preferred suppliers.
address the business challenges you face. Once the survey
data is collected, this same team creates a unique report Complimentary Consulting Provided
that presents the reader with a thorough understanding of With your purchase, we offer one free hour of consultation
the topic and the scientific and business implications of with our talented team of scientific and business analysts
the results based on sophisticated statistical analytics. who created the report. During this consultation, we can
answer any questions you may have about the survey
Custom Analysis & Research Available results and what we believe to be the significant trends
If you’d like to delve deeper into the data from a study, affecting the market.
we can always perform custom cross-tabulations or other
analysis on your behalf. We can even pose follow-up
questions to respondents who answered in a particular
way or conduct a custom study to extend your knowledge.

Invest in the most direct source of information from the scientists who buy your products,
and the expert team that has been monitoring your clients since 1994.

The Contract Research Market for Drug Discovery Technologies Executive Summary Page 2 of 4
©2009 BioInformatics, LLC
About BioInformatics, LLC Our strength lies in our ability to integrate our understanding of
science and medicine with cutting-edge market research techniques.
Since our inception in 1994, BioInformatics has provided critical As one of the first firms to recognize how the World Wide Web has
market intelligence to leading companies serving the life science, transformed market research, BioInformatics formed The Science
medical device and pharmaceutical industries. We support clients Advisory Board. Launched in 1997, this global community currently

Overview
across the entire market spectrum—from scientific research to consists of more than 46,000 life science researchers, physicians
diagnostics and therapeutics—providing high-level management with and biomedical professionals who convene regularly via the Web to
market insights from gene to drug. voice their opinions on a wide variety of issues relating to biomedical
research and clinical technologies. Clients tap into this panel of
Our multi-disciplinary team of scientific experts and business experts and receive answers to their critical marketing questions in
analysts creates value for our clients by combining extensive industry days, rather than weeks. In addition to providing real-time insights
knowledge and experience. We offer a variety of products and into the perceptions of the market, posing questions to The Science
services that enable executives to see themselves, their market and
Advisory Board offers substantial cost savings over gathering
their competitors through the eyes of the most important information
information via traditional market research techniques.

Company Information
source of all—customers. We can precisely meet the needs of our
clients through the most appropriate mix of research methodologies,
BioInformatics offers both published reports and custom research
including:
services. Published reports allow marketing professionals to share in
• Online Surveys
the results of broad-based market studies that provide access to high
• Focus Groups
quality research at an affordable price. Our custom research is tailored
• In-depth Interviews
to the specific needs of the company’s executive management. For
more information about BioInformatics’ product and service offerings,
please visit our Web site at www.gene2drug.com, call 703.778.3080
x13 or email information@gene2drug.com.

Our Valued Clients


Biotechnology/Life Science Eppendorf Plexagen Diagnostics Ortho-Clinical Diagnostics Phillip Johnson & Associates

Order Form
454 Eurogentec Post Genome Institute Radiometer America PA Consulting
AbCam Expression Pathology Promega Tektronix Perry Ballard
Accelrys Fermentas Protein Forest Piper Jaffray
Affymetrix Fluidigm Proteome Systems Pharmaceuticals Ruder Finn
Agencourt Bioscience GE Healthcare Qbiogene Abbott Laboratories Scherago International
Agilent Technologies Gen-Probe QIAGEN Amgen Select Equity Group
American Type Culture Gene Codes R & D Systems AstraZeneca Stephan & Brady
Collection Gene Logic Ribomed Biotechnologies Aventis The Strategy Works
Anachem Gene Therapy Systems Rosetta Biosoftware Baxter Healthcare UBS Warburg
Antibodies By Design Gentra Systems Sachem Bayer
Apple Computer GenVault Corporation Sarstedt Boehringer Ingelheim Publishers & Associations
Applied Biosystems Genzyme Sandia National Laboratories Pharmaceuticals Academic Press
Applied Precision Guava Technologies SAS Institute Cardinal Health American Academy of
Axxora Helicos BioSciences Schott Nexterion Centocor Pediatrics
BD Biosciences Hewlett-Packard Sequenom Hoechst Marion Roussel AAAS/Science
Beckman Coulter High Throughput Genomics Serologicals ICN Pharmaceuticals American Medical Association
Biacore Hitachi Instruments Serotec Janssen Pharmaceutica American Society for Cell
Bio-Rad Laboratories Hybrigenics Sigma-Aldrich Merck Biology
Bioneer Hyseq Solexa Novartis Pharmaceuticals American Society for
Biotage IBM Life Sciences SomaLogic Novo Nordisk Microbiology
BioTrove Illumina Source Precision Medicine Pharmaceuticals American Society of Human
Blue Heron Biotechnology Immunotech Stratagene Pfizer Genetics
Caliper Technologies InforMax Stressgen Biotechnologies Schering-Plough BioTechniques/Eaton
Callida Genomics Integrated DNA Technologies Takara Mirus Bio Publishing
Cambrex Bio Science Invitrogen Tecan Professional Services Blackwell Publishing
Carl Zeiss JRH Biosciences The Jackson Laboratory & Finance Cold Spring Harbor
Cell Signaling Technology Kirkegaard & Perry Thermo Fisher Scientific Adjuvant Partners Laboratory Press
Celliance Laboratories Thomas Scientific Adventus Research Elsevier
Charles River Laboratories Kodak Scientific Imaging Tocris Cookson Agency.com Federation of Amer. Societies
ChromaVision Medical Leica Microsystems Transgenomic Anvil Group for Experimental Biology
Systems LI-COR UVP Atlas Venture Harvard University Medical
Cipher Systems LION bioscience Varian Battelle Memorial Institute School
Clontech Laboratories Lonza VWR International BioOnline John Wiley & Sons
Corning Luminex Vysis Citadel Investment Group Mary Ann Liebert Publishers
DAKO MDS Sciex Waters Doran Media Services Nature Publishing Group
DNAStar Mettler-Toledo AutoChem Whatman Fidelity Management and New England Journal of
Dow Corning Millipore Research Medicine
Dynal Biotech MiraiBio Medical Diagnostics Foley & Lardner Society for Neuroscience
eBIOINFORMATICS Molecular Devices Applied Imaging Gerson Lehrman Group Springer-Verlag
Edge Biosystems MWG Biotech Ciba Corning Diagnostics HSBC Securities Stanford University High Wire
Eksigent Technologies New England Biolabs Infotrieve Press
Dade Behring
EM Separations Technology NuGEN Technologies Innovative Marketing Group Thomson ISI
Diagnostic Products
EMD Biosciences Ovid Technologies McKinsey & Co. Wolters Kluwer
Diametrics Medical
Entelechon Pall Life Sciences Hewlett-Packard Medical Nathan Associates
Epigenomics Percival Scientific Products National Research Council of
Epitomics PerkinElmer Life Sciences LifeScan Canada
Epoch Biosciences Photometrics Mallinckrodt Novintel

The Contract Research Market for Drug Discovery Technologies Executive Summary Page 3 of 4
©2009 BioInformatics, LLC
BioInformatics
REPORT #10-001 market insights from gene to drug

The Contract Research Market for Drug Discovery Technologies:


Opportunities for Life Science Suppliers

Overview
PRE-PUBLICATION DISCOUNT PRICES are only available until January 31, 2010!
Print — $3,200 Now $2,700!
Electronic (PDF) — $5,200 Now $4,500!
Print + Electronic — $5,200 Now $4,500!

Ordering Information Electronic Copy

Company Information
To place an order, fill out this form and mail it to BioInformatics, LLC or fax This format allows an unlimited number of users within your company
it to 703.778.3081. Alternatively, you may submit your order by emailing to access the report regardless of geographic location. You may place the
sales@gene2drug.com, calling 703.778.3080 or visiting electronic copy (PDF) on your secure, corporate intranet or share it with
www.gene2drug.com/order/206/. co-workers via email. In addition to providing greater accessibility, the
electronic copy allows you to easily navigate the document with the help
Payment must be made within 30 days and in U.S. dollars. of bookmarks, quickly search key words or phrases and print out any page.
BioInformatics’ Federal Tax ID #: 54-2001907. One print copy of the report is also provided at no additional cost.

Credit Card Data Set


You may charge your order to American Express, MasterCard, Visa, To accommodate your unique needs, the raw data is also available. With
Diner’s Card or Discover. Please include your credit card account number, the data, you can analyze respondents’ answer choices in any way needed,
expiration date and signature. including cross-tabulations, correlations, etc. The data set is offered in two
formats: SPSS® Base or Microsoft® Excel, and may only be purchased in
Wire Transfers conjunction with the company-wide electronic copy of the report.
Wire transfers should be sent to: SunTrust Bank, 2121 15th Street, Arlington,
VA 22201, SWIFT #SNTRUS3A, ABA #071000104, Account #702260169.

Order Form
I wish to order the following format of REPORT #10-001, The Contract Research Market for Drug Discovery Technologies
Discount Price
o Print $2,700 $________

o Electronic (PDF) $4,500 $________

o Print + Electronic $4,500 $________

o Add Data Set Excel or SPSS (circle one) +$1,200 +$________


Additional print copies _____ x $300 each +$________

Promo Code ___________ –$________


Shipping & Handling
(Add $15 for U.S., $50 for Int’l) +$________
Total $________

o Check Enclosed (Payable to BioInformatics, LLC)

o Purchase Order #_________________________________________


Name

Title

o Am Ex o MasterCard o Visa o Diner’s Card o Discover


Organization

Street Address
 /
Credit Card # Exp Date
(MM/YY)
City, State/Province, Postal Code Name on card______________________________________________

Country
Order Authorized By:
Phone Fax
__________________________________________________________
Signature Date
Email

BioInformatics, LLC
2111 Wilson Blvd., Suite 250 Arlington, VA 22201
Web: www.gene2drug.com • Phone: 703.778.3080 x13 • Fax: 703.778.3081 • Email: m.follin@gene2drug.com

The Contract Research Market for Drug Discovery Technologies Executive Summary Page 4 of 4
©2009 BioInformatics, LLC